Terns Pharmaceuticals Files 8-K
Ticker: TERN · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1831363
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
TL;DR
Terns Pharma filed an 8-K on 12/8/25 - check for updates.
AI Summary
On December 8, 2025, Terns Pharmaceuticals, Inc. filed an 8-K report. The filing indicates that the company is providing information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing signals that Terns Pharmaceuticals is making disclosures to the SEC, which could pertain to significant company events or financial updates.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific material events or financial data that would indicate immediate risk.
Key Players & Entities
- Terns Pharmaceuticals, Inc. (company) — Registrant
- December 08, 2025 (date) — Date of earliest event reported
- 001-39926 (other) — Commission File Number
- 98-1448275 (other) — IRS Employer Identification No.
- 1065 East Hillsdale Blvd. Suite 100 (address) — Principal Executive Offices
- Foster City, California (location) — Principal Executive Offices Location
- 94404 (zip_code) — Principal Executive Offices Zip Code
- (650) 525-5535 (phone_number) — Registrant's Telephone Number
FAQ
What specific event triggered this 8-K filing?
The filing indicates it is for Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits, but the specific triggering event is not detailed in the provided excerpt.
When was this 8-K report filed?
The report was filed as of December 08, 2025.
What is Terns Pharmaceuticals' principal executive office address?
The principal executive offices are located at 1065 East Hillsdale Blvd., Suite 100, Foster City, California, 94404.
What is the Commission File Number for Terns Pharmaceuticals?
The Commission File Number is 001-39926.
What is the SIC code for Terns Pharmaceuticals?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 2,157 words · 9 min read · ~7 pages · Grade level 16.5 · Accepted 2025-12-08 16:01:12
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value per share TERN Nasdaq Glo
Filing Documents
- d19462d8k.htm (8-K) — 88KB
- d19462dex991.htm (EX-99.1) — 63KB
- g19462g08q61.jpg (GRAPHIC) — 2KB
- 0001193125-25-311202.txt ( ) — 291KB
- tern-20251208.xsd (EX-101.SCH) — 3KB
- tern-20251208_lab.xml (EX-101.LAB) — 18KB
- tern-20251208_pre.xml (EX-101.PRE) — 11KB
- d19462d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, issued by Terns Pharmaceuticals, Inc. on December 8, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TERNS PHARMACEUTICALS, INC. Date: December 8, 2025 By: /s/ Caryn McDowell Caryn McDowell Chief Legal Officer and Corporate Secretary